StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.43+0.08 (+0.96%)

Close on Nov 18, 2026Market cap $529.97MP/E –Yield –

Electra Therapeutics cash

Cash and short-term investments held at the end of each period.

Electra Therapeutics's cash was $402.50M at Sep 30, 2026. For fiscal 2025 it was $86.52M.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$86.52M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$402.50M–
Q4 FY2025Dec 31, 2025$86.52M–

More Electra Therapeutics figures

See a number that looks wrong?